Measles-containing-vaccine second-dose (MCV2) … MCV2, WUENIC in Liberia
Liberia: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 60.0% in 2025. ◆ Volatile
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Liberia, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Liberia recorded 60.0% for measles-containing-vaccine second-dose (mcv2) immunization coverage in 2025. That is the highest value across all 26 years on record.
The figure is up 100.0% over five years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Liberia peaked at 60.0% in 2023 and was at its lowest, 0.0%, in 2000.
That places Liberia 160th out of 194 countries with data for 2025, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Liberia, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 0.0% | — |
| 2007 | 0.0% | — |
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 0.0% | — |
| 2015 | 0.0% | — |
| 2016 | 0.0% | — |
| 2017 | 0.0% | — |
| 2018 | 0.0% | — |
| 2019 | 13.0% | — |
| 2020 | 30.0% | +130.8% |
| 2021 | 35.0% | +16.7% |
| 2022 | 59.0% | +68.6% |
| 2023 | 60.0% | +1.7% |
| 2024 | 60.0% | +0.0% |
| 2025 | 60.0% | +0.0% |
Liberia compared with similar countries
- Liberia's 60.0% is above the median for low income countries, which is 60.0%, 1.0× the median. (25 countries reporting)
- Liberia's 60.0% is below the median for Sub-Saharan Africa, which is 66.0%, 91% of the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 10 |
| 2010s | 1.3% | 0.0% | 13.0% | 10 |
| 2020s | 50.7% | 30.0% | 60.0% | 6 |
Countries ranked near Liberia
- 158 Marshall Islands 61.0% compare
- 158 Bolivia 61.0% compare
- 160 Micronesia (country) 60.0% compare
- 162 Mauritania 59.0% compare
- 162 Lebanon 59.0% compare
More health data for Liberia
- Un projection of annual infant deaths, annual growth rate -1.57 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7528 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,097 deaths per 1,000 people (2090)
- Number of infants who die before age 1 3,457 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 7 (2025)
- Population ages 00-04, female, annual growth rate 1.13 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.068 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.13 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Liberia?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Liberia was 60.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Liberia?
- The highest recorded value was 60.0% in 2023.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Liberia?
- The lowest recorded value was 0.0% in 2000.
- How does Liberia rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Liberia ranks 160th out of 194 countries with data for 2025.
- Where does this Liberia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).